Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine

NCT05846230 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

268

Enrollment

INDUSTRY

Sponsor class

Conditions

Bronchiectasis

Interventions

DRUG: BI 1291583
DRUG: Placebo matching BI 1291583

Sponsor

Boehringer Ingelheim